Temasek Holdings’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-84,938
Closed -$9.95M 74
2020
Q4
$9.95M Buy
+84,938
New +$9.35M 0.04% 61
2018
Q3
Sell
-107,300
Closed -$9.19M 60
2018
Q2
$9.19M Buy
107,300
+44,300
+70% +$3.7M 0.05% 53
2018
Q1
$5.05M Hold
63,000
0.03% 63
2017
Q4
$5.09M Buy
+63,000
New +$5.05M 0.03% 59
2015
Q3
Sell
-2,944,829
Closed -$218M 27
2015
Q2
$218M Buy
+2,944,829
New +$225M 1.36% 17

Other funds holding MDT

Temasek Holdings's MDT Position: Q1 2021 in Review

Temasek Holdings sold out of Medtronic (MDT) in Q1 2021, closing a stake of 84,938 shares — an estimated $9.95M sold.

Temasek Holdings first reported a position in MDT in Q2 2015 and held it in 5 quarters. The position peaked at $218M in Q2 2015. 1,976 funds tracked by Wall St. Rank hold MDT as of Q1 2021.

  • Temasek Holdings reported no remaining Medtronic position as of Q1 2021 after selling out during the quarter.
  • Temasek Holdings sold 84,938 Medtronic shares in Q1 2021, an estimated $9.95M.
  • Temasek Holdings first reported a position in Medtronic in Q2 2015 and held it in 5 quarters.
  • Temasek Holdings's Medtronic position peaked at $218M in Q2 2015.
  • 1,976 funds tracked by Wall St. Rank held Medtronic as of Q1 2021.

Based on Temasek Holdings's 13F filing for Q1 2021, filed 17 May 2021.